Andy

What does the vendor say it does?

The homepage calls Andy "the leading home health AI platform that handles documentation, quality and compliance." Three functions are described. Ambient scribing of home health visits goes into the agency EHR, including OASIS items, and the Y Combinator launch post says it turns 90 minutes of documentation into a 15-minute review. Built-in QA compares each visit with the H&P and earlier visits. Coding is described as AI coding "100% reviewed by home health coders."

The vendor's reported results are a 7% higher case-mix weight, under five days from visit to export and double the patient visits, with the caveat that results vary by agency.

Who is Andy AI, Inc., and how is it funded?

Andy AI, Inc. is at 2261 Market Street, Suite 10113, San Francisco. Tiantian Zha is CEO and Max Akhterov is CTO.

Funding figures disagree. CB Insights and Caplight report US$500,000 over two rounds, including a convertible note in April 2024, and Dealroom reports US$625,000 from Y Combinator, F7 Ventures and Headwater Ventures. The homepage shows seven agency logos, among them Compassionate, Chambers Home Health & Hospice and Lucent Health Group. It gives no customer count.

Which EMRs, and what compliance?

The homepage says Andy "works with major home health EMRs" without naming one. It describes the product as HIPAA compliant and gives no SOC 2 status.

Is there a price list?

Nothing is published beyond a comparison. The homepage says Andy costs "less than the cost of outsourced QA or coding," and a demo has to be booked.

Which agencies is it aimed at?

Home health agencies that currently outsource QA or coding are the buyer the vendor addresses. Apricot, which sells to the same agencies, builds its flow on a guided post-visit debrief interview, where Andy says it records the visit itself.

The verdict

CB Insights and Caplight put Andy's funding at US$500,000 and Dealroom at US$625,000, so the size of its backing is unsettled.